CA1037475A - Lactam compounds and conjugates - Google Patents

Lactam compounds and conjugates

Info

Publication number
CA1037475A
CA1037475A CA225,944A CA225944A CA1037475A CA 1037475 A CA1037475 A CA 1037475A CA 225944 A CA225944 A CA 225944A CA 1037475 A CA1037475 A CA 1037475A
Authority
CA
Canada
Prior art keywords
antigen
carbon atoms
oxygen
imino
bond
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA225,944A
Other languages
English (en)
French (fr)
Other versions
CA225944S (en
Inventor
Michael J. Soffer
Gunner Bolz
Richard K. Leute
Prithipal Singh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syva Co
Original Assignee
Syva Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syva Co filed Critical Syva Co
Application granted granted Critical
Publication of CA1037475A publication Critical patent/CA1037475A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9446—Antibacterials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pyrrole Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA225,944A 1974-06-28 1975-04-30 Lactam compounds and conjugates Expired CA1037475A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48402674A 1974-06-28 1974-06-28

Publications (1)

Publication Number Publication Date
CA1037475A true CA1037475A (en) 1978-08-29

Family

ID=23922433

Family Applications (1)

Application Number Title Priority Date Filing Date
CA225,944A Expired CA1037475A (en) 1974-06-28 1975-04-30 Lactam compounds and conjugates

Country Status (5)

Country Link
JP (1) JPS511632A (enFirst)
CA (1) CA1037475A (enFirst)
DE (1) DE2521523A1 (enFirst)
FR (1) FR2276317A1 (enFirst)
GB (1) GB1511571A (enFirst)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101863834A (zh) * 2010-06-29 2010-10-20 渤海大学 S-羧甲基-5,5-二苯基-2-硫代海因的制备方法

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069105A (en) * 1977-03-03 1978-01-17 Syva Company Lidocaine antigens and antibodies
US4156081A (en) * 1977-04-15 1979-05-22 Syva Company Theophylline antigens and antibodies
IL68364A (en) * 1982-06-01 1986-07-31 Miles Lab Ethosuximide immunogens,antibodies prepared therefrom and the use of such antibodies in immunoassays
DE3682105D1 (de) * 1985-04-01 1991-11-28 Abbott Lab Probe, tracers, immunogene und antikoerper von ethosuximid.
DE3924705A1 (de) * 1989-07-26 1991-01-31 Boehringer Mannheim Gmbh Heterobifunktionelle verbindungen
KR102267919B1 (ko) 2018-06-28 2021-06-23 주식회사 고영테크놀러지 기판에 실장된 부품의 실장 불량 원인을 결정하는 전자 장치 및 방법
WO2020111756A1 (ko) 2018-11-27 2020-06-04 주식회사 고영테크놀러지 기판에 대한 검사 결과를 표시하는 전자 장치 및 방법
CN115372501B (zh) * 2022-07-27 2024-03-26 广州科曼生物科技有限公司 一种浙贝母或湖北贝母对照提取物及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3817837A (en) * 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101863834A (zh) * 2010-06-29 2010-10-20 渤海大学 S-羧甲基-5,5-二苯基-2-硫代海因的制备方法

Also Published As

Publication number Publication date
JPS638427B2 (enFirst) 1988-02-23
GB1511571A (en) 1978-05-24
JPS511632A (en) 1976-01-08
FR2276317A1 (fr) 1976-01-23
FR2276317B1 (enFirst) 1979-04-27
DE2521523A1 (de) 1976-01-15

Similar Documents

Publication Publication Date Title
CA1230114A (en) Nitroxyl compounds, process for their preparation, and diagnostic media containing same
SU639445A3 (ru) Способ получени ациланилинов
US6057096A (en) Photocleavable agents and conjugates for the detection and isolation of biomolecules
CA1037475A (en) Lactam compounds and conjugates
JPH075623B2 (ja) モノホスホリルリピドａの誘導体
WO1989001475A1 (en) Tri-aza macrocycles and metal complexes thereof
EP0287465A1 (fr) Ligands cycliques azotés, complexes métalliques formés par ces ligands, compositions de diagnostic contenant ces complexes et procédé de préparation des ligands
KR890003784A (ko) 바나딜 유기-무기 화합물, 이 화합물의 제조방법, 이 유기-무기 화합물을 함유하는 제약학적 조성물
PT1987048E (pt) Processos para a síntese convergente de derivados de caliqueamicina
US9085535B2 (en) Method and substances for the preparation of N-substituted pyridinium compounds
Kashelikar et al. An Oxygen-18 Study of the Dehydration of Asparagine Amide with NN'-Dicyclohexylcarbodiimide and p-Toluenesulfonyl Chloride
Ouari et al. Synthesis and spin-trapping behaviour of glycosylated nitrones
DE69520561T2 (de) Phenylborsaurekomplexe
Li et al. Cholic acid as template for multivalent peptide assembly
Clavé et al. A universal and ready-to-use heterotrifunctional cross-linking reagent for facile synthetic access to sophisticated bioconjugates
US20100221749A1 (en) Three-functional pseudo-peptidic reagent, and uses and applications thereof
McLean et al. Radical‐mediated acyl thiol‐ene reaction for rapid synthesis of biomolecular thioester derivatives
CN113173891A (zh) 一种钙敏感受体蛋白拮抗剂衍生的分子探针及在甲状旁腺切除手术中的应用
CA1050993A (en) Dithiobis-(succinimidyl propionate)
CN109608479A (zh) 一种毒鼠强半抗原及单克隆抗体的制备方法与应用
WO1986000898A1 (en) Compounds for site-enhanced delivery of radionuclides and uses thereof
IL31169A (en) Penicilloic acid derivatives and process for the manufacture thereof
SK18295A3 (en) 3- and 5-substituted 1,2,3,4-oxatriazole -5-imine compounds, method of their preparation, pharmaceutical agent containing these compounds and their use for prepare of medicine
Suchý et al. A new synthesis of cystamine modified Eu 3+ DOTAM-Gly-Phe-OH: a conjugation ready temperature sensitive MRI contrast agent
KR840000488A (ko) 프롤린 유도체의 제법